Efficacy and safety assessment of retinol palmitate (Vitamin A) for acute brain infarction, phaseI and multi-center, randomized controlled, phaseII trial.
Phase 1
Recruiting
- Conditions
- Brain infarction
- Registration Number
- JPRN-UMIN000015513
- Lead Sponsor
- Department of Neurology , Graduate School of Medicine, Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with pregnancy. 2)Patinents who take Vitamin A derivative (Etretinate/ tretinoin/ tamibarotene). 3)Patients with serious organ damage. 4)Patients who are considered inappropriate to participate in the study by principal investigator.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method